author_facet Chabrol, Fanny
Noah Noah, Dominique
Tchoumi, Eric Pascal
Vidal, Laurent
Kuaban, Christopher
Carrieri, Maria Patrizia
Boyer, Sylvie
Chabrol, Fanny
Noah Noah, Dominique
Tchoumi, Eric Pascal
Vidal, Laurent
Kuaban, Christopher
Carrieri, Maria Patrizia
Boyer, Sylvie
author Chabrol, Fanny
Noah Noah, Dominique
Tchoumi, Eric Pascal
Vidal, Laurent
Kuaban, Christopher
Carrieri, Maria Patrizia
Boyer, Sylvie
spellingShingle Chabrol, Fanny
Noah Noah, Dominique
Tchoumi, Eric Pascal
Vidal, Laurent
Kuaban, Christopher
Carrieri, Maria Patrizia
Boyer, Sylvie
BMJ Open
Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
General Medicine
author_sort chabrol, fanny
spelling Chabrol, Fanny Noah Noah, Dominique Tchoumi, Eric Pascal Vidal, Laurent Kuaban, Christopher Carrieri, Maria Patrizia Boyer, Sylvie 2044-6055 2044-6055 BMJ General Medicine http://dx.doi.org/10.1136/bmjopen-2018-025415 <jats:sec><jats:title>Objectives</jats:title><jats:p>To document patients’ and healthcare professionals’ (HCP) experiences with hepatitis B virus (HBV) and hepatitis C virus (HCV) diagnosis and care, as well as consequences of these infections on patients’ life trajectories in Cameroon, an endemic country in sub-Saharan Africa.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Qualitative sociological study combining in-depth interviews and observations of medical consultations. Interviews and observations transcripts were thematically analysed according to the following themes: circumstances and perceptions surrounding hepatitis screening, counselling and disclosure, information provided by HCP on hepatitis prevention and treatment, experience of access to care and treatment, social/economic trajectories after diagnosis.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>HIV and gastroenterology/medical services in two reference public hospitals in Yaoundé (Cameroon).</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>12 patients affected by HBV and/or HCV (co-infected or not with HIV), 14 HCP, 14 state and international stakeholders.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Many patients are screened for HBV and HCV at a time of great emotional and economic vulnerability. The information and counselling delivered after diagnosis is limited and patients report feeling alone, distressed and unprepared to cope with their infection. After screening positive, patients struggle with out-of-pocket expenditures related to the large number of tests prescribed by physicians to assess disease stage and to decide whether treatment is needed. These costs are so exorbitant that many decide against clinical and biological follow-up. For those who do pay, the consequences on their social and economic life trajectories are catastrophic.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Large out-of-pocket expenditures related to biological follow-up and treatment pose a real challenge to receiving appropriate care. Free or reasonably priced access to hepatitis B and C treatments can only be effective and efficient at reducing the hepatitis disease burden if the screening algorithm and the whole pretherapeutic assessment package are simplified, standardised and subsidised by comprehensive national policies orientated towards universal healthcare.</jats:p></jats:sec> Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs BMJ Open
doi_str_mv 10.1136/bmjopen-2018-025415
facet_avail Online
Free
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9ibWpvcGVuLTIwMTgtMDI1NDE1
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9ibWpvcGVuLTIwMTgtMDI1NDE1
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint BMJ, 2019
imprint_str_mv BMJ, 2019
issn 2044-6055
issn_str_mv 2044-6055
language English
mega_collection BMJ (CrossRef)
match_str chabrol2019screeningdiagnosisandcarecascadeforviralhepatitisbandcinyaoundecameroonaqualitativestudyofpatientsandhealthproviderscopingwithuncertaintyandunbearablecosts
publishDateSort 2019
publisher BMJ
recordtype ai
record_format ai
series BMJ Open
source_id 49
title Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_unstemmed Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_full Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_fullStr Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_full_unstemmed Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_short Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_sort screening, diagnosis and care cascade for viral hepatitis b and c in yaoundé, cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
topic General Medicine
url http://dx.doi.org/10.1136/bmjopen-2018-025415
publishDate 2019
physical e025415
description <jats:sec><jats:title>Objectives</jats:title><jats:p>To document patients’ and healthcare professionals’ (HCP) experiences with hepatitis B virus (HBV) and hepatitis C virus (HCV) diagnosis and care, as well as consequences of these infections on patients’ life trajectories in Cameroon, an endemic country in sub-Saharan Africa.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Qualitative sociological study combining in-depth interviews and observations of medical consultations. Interviews and observations transcripts were thematically analysed according to the following themes: circumstances and perceptions surrounding hepatitis screening, counselling and disclosure, information provided by HCP on hepatitis prevention and treatment, experience of access to care and treatment, social/economic trajectories after diagnosis.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>HIV and gastroenterology/medical services in two reference public hospitals in Yaoundé (Cameroon).</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>12 patients affected by HBV and/or HCV (co-infected or not with HIV), 14 HCP, 14 state and international stakeholders.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Many patients are screened for HBV and HCV at a time of great emotional and economic vulnerability. The information and counselling delivered after diagnosis is limited and patients report feeling alone, distressed and unprepared to cope with their infection. After screening positive, patients struggle with out-of-pocket expenditures related to the large number of tests prescribed by physicians to assess disease stage and to decide whether treatment is needed. These costs are so exorbitant that many decide against clinical and biological follow-up. For those who do pay, the consequences on their social and economic life trajectories are catastrophic.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Large out-of-pocket expenditures related to biological follow-up and treatment pose a real challenge to receiving appropriate care. Free or reasonably priced access to hepatitis B and C treatments can only be effective and efficient at reducing the hepatitis disease burden if the screening algorithm and the whole pretherapeutic assessment package are simplified, standardised and subsidised by comprehensive national policies orientated towards universal healthcare.</jats:p></jats:sec>
container_issue 3
container_start_page 0
container_title BMJ Open
container_volume 9
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792340697750175746
geogr_code not assigned
last_indexed 2024-03-01T16:06:57.239Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Screening%2C+diagnosis+and+care+cascade+for+viral+hepatitis+B+and+C+in+Yaound%C3%A9%2C+Cameroon%3A+a+qualitative+study+of+patients+and+health+providers+coping+with+uncertainty+and+unbearable+costs&rft.date=2019-03-01&genre=article&issn=2044-6055&volume=9&issue=3&pages=e025415&jtitle=BMJ+Open&atitle=Screening%2C+diagnosis+and+care+cascade+for+viral+hepatitis+B+and+C+in+Yaound%C3%A9%2C+Cameroon%3A+a+qualitative+study+of+patients+and+health+providers+coping+with+uncertainty+and+unbearable+costs&aulast=Boyer&aufirst=Sylvie&rft_id=info%3Adoi%2F10.1136%2Fbmjopen-2018-025415&rft.language%5B0%5D=eng
SOLR
_version_ 1792340697750175746
author Chabrol, Fanny, Noah Noah, Dominique, Tchoumi, Eric Pascal, Vidal, Laurent, Kuaban, Christopher, Carrieri, Maria Patrizia, Boyer, Sylvie
author_facet Chabrol, Fanny, Noah Noah, Dominique, Tchoumi, Eric Pascal, Vidal, Laurent, Kuaban, Christopher, Carrieri, Maria Patrizia, Boyer, Sylvie, Chabrol, Fanny, Noah Noah, Dominique, Tchoumi, Eric Pascal, Vidal, Laurent, Kuaban, Christopher, Carrieri, Maria Patrizia, Boyer, Sylvie
author_sort chabrol, fanny
container_issue 3
container_start_page 0
container_title BMJ Open
container_volume 9
description <jats:sec><jats:title>Objectives</jats:title><jats:p>To document patients’ and healthcare professionals’ (HCP) experiences with hepatitis B virus (HBV) and hepatitis C virus (HCV) diagnosis and care, as well as consequences of these infections on patients’ life trajectories in Cameroon, an endemic country in sub-Saharan Africa.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Qualitative sociological study combining in-depth interviews and observations of medical consultations. Interviews and observations transcripts were thematically analysed according to the following themes: circumstances and perceptions surrounding hepatitis screening, counselling and disclosure, information provided by HCP on hepatitis prevention and treatment, experience of access to care and treatment, social/economic trajectories after diagnosis.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>HIV and gastroenterology/medical services in two reference public hospitals in Yaoundé (Cameroon).</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>12 patients affected by HBV and/or HCV (co-infected or not with HIV), 14 HCP, 14 state and international stakeholders.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Many patients are screened for HBV and HCV at a time of great emotional and economic vulnerability. The information and counselling delivered after diagnosis is limited and patients report feeling alone, distressed and unprepared to cope with their infection. After screening positive, patients struggle with out-of-pocket expenditures related to the large number of tests prescribed by physicians to assess disease stage and to decide whether treatment is needed. These costs are so exorbitant that many decide against clinical and biological follow-up. For those who do pay, the consequences on their social and economic life trajectories are catastrophic.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Large out-of-pocket expenditures related to biological follow-up and treatment pose a real challenge to receiving appropriate care. Free or reasonably priced access to hepatitis B and C treatments can only be effective and efficient at reducing the hepatitis disease burden if the screening algorithm and the whole pretherapeutic assessment package are simplified, standardised and subsidised by comprehensive national policies orientated towards universal healthcare.</jats:p></jats:sec>
doi_str_mv 10.1136/bmjopen-2018-025415
facet_avail Online, Free
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTEzNi9ibWpvcGVuLTIwMTgtMDI1NDE1
imprint BMJ, 2019
imprint_str_mv BMJ, 2019
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 2044-6055
issn_str_mv 2044-6055
language English
last_indexed 2024-03-01T16:06:57.239Z
match_str chabrol2019screeningdiagnosisandcarecascadeforviralhepatitisbandcinyaoundecameroonaqualitativestudyofpatientsandhealthproviderscopingwithuncertaintyandunbearablecosts
mega_collection BMJ (CrossRef)
physical e025415
publishDate 2019
publishDateSort 2019
publisher BMJ
record_format ai
recordtype ai
series BMJ Open
source_id 49
spelling Chabrol, Fanny Noah Noah, Dominique Tchoumi, Eric Pascal Vidal, Laurent Kuaban, Christopher Carrieri, Maria Patrizia Boyer, Sylvie 2044-6055 2044-6055 BMJ General Medicine http://dx.doi.org/10.1136/bmjopen-2018-025415 <jats:sec><jats:title>Objectives</jats:title><jats:p>To document patients’ and healthcare professionals’ (HCP) experiences with hepatitis B virus (HBV) and hepatitis C virus (HCV) diagnosis and care, as well as consequences of these infections on patients’ life trajectories in Cameroon, an endemic country in sub-Saharan Africa.</jats:p></jats:sec><jats:sec><jats:title>Design</jats:title><jats:p>Qualitative sociological study combining in-depth interviews and observations of medical consultations. Interviews and observations transcripts were thematically analysed according to the following themes: circumstances and perceptions surrounding hepatitis screening, counselling and disclosure, information provided by HCP on hepatitis prevention and treatment, experience of access to care and treatment, social/economic trajectories after diagnosis.</jats:p></jats:sec><jats:sec><jats:title>Setting</jats:title><jats:p>HIV and gastroenterology/medical services in two reference public hospitals in Yaoundé (Cameroon).</jats:p></jats:sec><jats:sec><jats:title>Participants</jats:title><jats:p>12 patients affected by HBV and/or HCV (co-infected or not with HIV), 14 HCP, 14 state and international stakeholders.</jats:p></jats:sec><jats:sec><jats:title>Findings</jats:title><jats:p>Many patients are screened for HBV and HCV at a time of great emotional and economic vulnerability. The information and counselling delivered after diagnosis is limited and patients report feeling alone, distressed and unprepared to cope with their infection. After screening positive, patients struggle with out-of-pocket expenditures related to the large number of tests prescribed by physicians to assess disease stage and to decide whether treatment is needed. These costs are so exorbitant that many decide against clinical and biological follow-up. For those who do pay, the consequences on their social and economic life trajectories are catastrophic.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>Large out-of-pocket expenditures related to biological follow-up and treatment pose a real challenge to receiving appropriate care. Free or reasonably priced access to hepatitis B and C treatments can only be effective and efficient at reducing the hepatitis disease burden if the screening algorithm and the whole pretherapeutic assessment package are simplified, standardised and subsidised by comprehensive national policies orientated towards universal healthcare.</jats:p></jats:sec> Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs BMJ Open
spellingShingle Chabrol, Fanny, Noah Noah, Dominique, Tchoumi, Eric Pascal, Vidal, Laurent, Kuaban, Christopher, Carrieri, Maria Patrizia, Boyer, Sylvie, BMJ Open, Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs, General Medicine
title Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_full Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_fullStr Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_full_unstemmed Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_short Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_sort screening, diagnosis and care cascade for viral hepatitis b and c in yaoundé, cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
title_unstemmed Screening, diagnosis and care cascade for viral hepatitis B and C in Yaoundé, Cameroon: a qualitative study of patients and health providers coping with uncertainty and unbearable costs
topic General Medicine
url http://dx.doi.org/10.1136/bmjopen-2018-025415